Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Arch. Soc. Esp. Oftalmol ; 92(10): 495-498, oct. 2017. ilus
Article in Spanish | IBECS | ID: ibc-167447

ABSTRACT

Caso clínico: Mujer de 71 años, diagnosticada de glaucoma primario de ángulo abierto normotensional; presentó de forma asintomática, en el ojo con daño glaucomatoso más avanzado, una retinosquisis peripapilar temporal con desprendimiento de retina seroso subyacente, mayor en la porción inferior del disco donde existía un defecto focal. Discusión: Aunque las fosetas congénitas son las que más se asocian con la retinosquisis peripapilar, esta también puede surgir a partir de defectos adquiridos en las proximidades de las papilas glaucomatosas. Dependiendo de su extensión esta complicación puede ser asintomática, por lo que su prevalencia podría ser mayor de la publicada (AU)


Clinical case: A 71-year-old woman with normotensive primary open-angle glaucoma presented with an asymptomatic temporal peripapillary retinoschisis, associated with serous retinal detachment in the eye with the more advanced glaucoma. It was located at the inferior pole of the optic disc, in the proximity of a glaucomatous focal disc defect. Discussion: Although congenital optic pits are strongly related with juxta-papillary retinoschisis, retinoschisis can also arise from acquired defects in the proximity of glaucomatous optic discs. As symptoms depend on the extent of the retinoschisis, the prevalence of this complication could be greater than that reported in glaucomatous eyes (AU)


Subject(s)
Humans , Female , Aged , Retinoschisis/complications , Glaucoma/complications , Retinal Detachment/complications , Optic Disk/abnormalities , Tomography, Optical Coherence , Risk Factors
2.
Arch Soc Esp Oftalmol ; 92(10): 495-498, 2017 Oct.
Article in English, Spanish | MEDLINE | ID: mdl-27887794

ABSTRACT

CLINICAL CASE: A 71-year-old woman with normotensive primary open-angle glaucoma presented with an asymptomatic temporal peripapillary retinoschisis, associated with serous retinal detachment in the eye with the more advanced glaucoma. It was located at the inferior pole of the optic disc, in the proximity of a glaucomatous focal disc defect. DISCUSSION: Although congenital optic pits are strongly related with juxta-papillary retinoschisis, retinoschisis can also arise from acquired defects in the proximity of glaucomatous optic discs. As symptoms depend on the extent of the retinoschisis, the prevalence of this complication could be greater than that reported in glaucomatous eyes.


Subject(s)
Glaucoma, Open-Angle/complications , Retinal Detachment/etiology , Retinoschisis/etiology , Aged , Asymptomatic Diseases , Female , Humans
3.
Arch. Soc. Esp. Oftalmol ; 91(3): 114-119, mar. 2016. graf, tab
Article in Spanish | IBECS | ID: ibc-148075

ABSTRACT

OBJETIVO: Analizar las indicaciones, dosis y eficacia de las inyecciones de toxina botulínica A en el departamento de Estrabología. MÉTODO: En este estudio prospectivo, 28 pacientes diagnosticados de estrabismo fueron tratados con toxina botulínica. Se recopilaron los pacientes tratados en 2013 en el Hospital Rey Juan Carlos (Móstoles) para estudiar las indicaciones, la dosis empleada, y se analizaron los resultados de la última revisión, tanto en niños como en adultos, con un seguimiento mínimo de 14 meses. RESULTADOS: Se recogieron datos de 11 niños, 6 mujeres (54,5%), y 17 adultos, 11 varones (64%). La edad media fue 4,42 ± 3,48 años y 58,71 ± 18,07 años en niños y adultos respectivamente. En ambos grupos la mayoría de los casos eran endotropias (81,8% en niños y 47,1% en adultos), aunque el grupo de adultos presentaba enfermedades más heterogéneas incluyendo 4 pacientes con exotropía (26,5%), 4 con hipertropía (26,5%) y uno con nistagmo aislado (5,9%). La media de inyecciones en niños fue de 1,45 ± 0,93, aunque el 72,7% recibieron una única inyección; en el grupo de adultos la media de inyecciones fue de 3,27 ± 1,41. Se encontró una diferencia estadísticamente significativa en la comparación de tropia y foria prepostinyección en niños y adultos (p < 0,05). En ambos grupos hubo una mejoría significativa en el tortícolis postinyección comparado con el previo (p < 0,05). En 4 niños pudimos detectar una mejoría en la estereoagudeza. Dos niños (18,2%) y 5 adultos (29,4%) precisaron intervención quirúrgica posterior. Ocho adultos (49,1%) presentaban diplopia en posición primaria de la mirada, que se resolvió en 6 casos con inyecciones de toxina, pero 2 necesitaron cirugía para la corrección de la diplopia. Las diferencias entre tropia y foria pre- y postintervención fueron estadísticamente significativas (p < 0,05), así como las diferencias entre el tortícolis pre- y postinyección. En 4 casos se pudo detectar mejoría en la estereoagudeza. CONCLUSIONES: La toxina botulínica es un fármaco muy útil en el estrabismo, con mejores resultados sensoriales y motores en los niños, pero eficaz como tratamiento sintomático en algunos casos de estrabismo en adultos


OBJECTIVE: To analyse the indications, dosage and efficacy of botulinum toxin A injection performed in patients in a Strabismus Department. METHODS: In this prospective study, botulinum toxin A was injected into 28 patients diagnosed with strabismus. Data was obtained from the records of patients that were evaluated during 2013 in the Strabismus Unit of Rey Juan Carlos Hospital (Móstoles, Madrid, Spain) in order to assess the indications and dosage of botulinum toxin A use in strabismus, as well as its clinical effect and differences in paediatric and adult patients. The outcomes in the last visit, at least 14 months after the injections, were analysed. RESULTS: An analysis was performed on the data from 11 children, 6 females (54.5%), and 17 adults, 11 males (64%). The mean age was 4.42 ± 3.48 years and 58.71 ± 18.07 years in the children and adult groups, respectively. The majority of cases in both groups were esotropia (81.8% in children and 47.1% in adults). However the pathologies in the adult group were quite heterogeneous, including 4 patients with exotropia (26.5%), 4 with hypertropia (26.5%), and one with isolated nystagmus (5.9%). The mean number of the botulinum toxin injections in children was 1.45 ± 0.93, although 72.7% received a single injection. In the adult group, the mean number of injections was 3.27 ± 1.41. There was a statistically significant difference between pre- and post-injection in the tropia and phoria measurements in children and adults group (P<.05). In both groups there was a statistically significant improvement in post-injection torticollis when compared with the pre-injection measurement (P<.05). An improvement in the stereoacuity could be detected in 4 children. Two children (18.2%) and 5 adults (29.4%) required subsequent surgical intervention. Eight adult patients (49.1%) complained of diplopia in the primary position, which was resolved in 6 cases with toxin injection, whereas 2 needed surgery for diplopia correction. CONCLUSIONS: Botulinum toxin is a very useful tool in the management of strabismus, obtaining better sensory and motor results in children, but it is also effective as a symptomatic treatment in some types of strabismus in adults


Subject(s)
Humans , Male , Female , Child , Adult , Middle Aged , Strabismus/therapy , Botulinum Toxins, Type A/economics , Botulinum Toxins, Type A/pharmacokinetics , Botulinum Toxins, Type A/therapeutic use , Diplopia/drug therapy , Dexamethasone/therapeutic use , Tobramycin/therapeutic use , Botulinum Toxins, Type A/administration & dosage , Botulinum Toxins, Type A , Prospective Studies , Torticollis/complications , Torticollis/drug therapy , Cohort Studies , /methods , Evaluation of Results of Therapeutic Interventions/trends
4.
Arch Soc Esp Oftalmol ; 91(3): 114-9, 2016 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-26749329

ABSTRACT

OBJECTIVE: To analyse the indications, dosage and efficacy of botulinum toxin A injection performed in patients in a Strabismus Department. METHODS: In this prospective study, botulinum toxin A was injected into 28 patients diagnosed with strabismus. Data was obtained from the records of patients that were evaluated during 2013 in the Strabismus Unit of Rey Juan Carlos Hospital (Móstoles, Madrid, Spain) in order to assess the indications and dosage of botulinum toxin A use in strabismus, as well as its clinical effect and differences in paediatric and adult patients. The outcomes in the last visit, at least 14 months after the injections, were analysed. RESULTS: An analysis was performed on the data from 11 children, 6 females (54.5%), and 17 adults, 11 males (64%). The mean age was 4.42±3.48 years and 58.71±18.07 years in the children and adult groups, respectively. The majority of cases in both groups were esotropia (81.8% in children and 47.1% in adults). However the pathologies in the adult group were quite heterogeneous, including 4 patients with exotropia (26.5%), 4 with hypertropia (26.5%), and one with isolated nystagmus (5.9%). The mean number of the botulinum toxin injections in children was 1.45±0.93, although 72.7% received a single injection. In the adult group, the mean number of injections was 3.27±1.41. There was a statistically significant difference between pre- and post-injection in the tropia and phoria measurements in children and adults group (P<.05). In both groups there was a statistically significant improvement in post-injection torticollis when compared with the pre-injection measurement (P<.05). An improvement in the stereoacuity could be detected in 4 children. Two children (18.2%) and 5 adults (29.4%) required subsequent surgical intervention. Eight adult patients (49.1%) complained of diplopia in the primary position, which was resolved in 6 cases with toxin injection, whereas 2 needed surgery for diplopia correction. CONCLUSIONS: Botulinum toxin is a very useful tool in the management of strabismus, obtaining better sensory and motor results in children, but it is also effective as a symptomatic treatment in some types of strabismus in adults.


Subject(s)
Botulinum Toxins/therapeutic use , Strabismus/drug therapy , Adult , Botulinum Toxins, Type A , Child , Child, Preschool , Female , Hospitals, General , Humans , Infant , Male , Oculomotor Muscles/surgery , Prospective Studies , Spain , Treatment Outcome
5.
Arch. Soc. Esp. Oftalmol ; 90(4): 156-163, abr. 2015. ilus, tab
Article in Spanish | IBECS | ID: ibc-136933

ABSTRACT

OBJETIVO: Evaluar parámetros morfológicos maculares determinados mediante tomografía de coherencia óptica de dominio espectral (SD-OCT) como factores predictivos de la respuesta funcional en pacientes con degeneración macular asociada a la edad (DMAE) de tipo exudativo tratados con ranibizumab. MÉTODOS: Estudio retrospectivo de 47 pacientes diagnosticados de DMAE exudativa y tratados con ranibizumab intravítreo durante 12 meses. Mediante SD-OCT se evaluaron el grosor retiniano central (CRT), la extensión y el grosor de las alteraciones secundarias al proceso neovascular, y el estado de las bandas correspondientes a la membrana limitante externa (MLE) y a la región elipsoide de los fotorreceptores (ISe), analizándose por métodos estadísticos la relación entre estas variables y la agudeza visual. RESULTADOS: Al diagnóstico, la conservación de las bandas MLE e ISe y el CRT se correlaciona con la visión inicial. Doce meses después, el CRT y la visión final son parámetros independientes. Los análisis bivariante mostraron correlación entre la agudeza visual final y los siguientes parámetros: CRT inicial, estado inicial de las bandas ISe y MLE, y estado de estas tras la dosis de carga. El análisis de regresión lineal múltiple indica que la visión inicial y el estado de la banda ISe tras la fase de carga tienen valor predictivo de la visión final. CONCLUSIONES: El estado de conservación de las bandas ISe y MLE tras 12 meses de tratamiento con ranibizumab se correlaciona con el resultado visual. La agudeza visual inicial y el estado de la banda ISe tras la fase de carga son factores pronóstico de la agudeza visual final


OBJECTIVE: To evaluate macular morphological parameters measured by spectral domain optical coherence tomography (SD-OCT) as predictive factors of visual outcome in patients with exudative age-related macular degeneration (AMD) treated with ranibizumab. METHODS: A retrospective study was conducted on 47 patients diagnosed with exudative AMD and treated with intravitreal ranibizumab for twelve months. Central retinal thickness (CRT), extension and thickness of modifications secondary to neovascular process, and status of the bands corresponding to the external limiting membrane (ELM) and to the ellipsoid region of the photoreceptors (ISe) were evaluated by means of SD-OCT. The relationship between these variables and visual acuity was analyzed by statistical methods. RESULTS: At the time of the diagnosis, preservation of ELM and ISe bands, and CRT were correlated with initial visual acuity. Twelve months later, CRT and visual acuity were independent parameters. Bivariate relationship analysis showed a correlation between final visual acuity and the following parameters: initial CRT, initial ISe and ELM status, and ISe and ELM integrity after loading dose. Multiple regression analysis indicated that initial visual acuity and ISe band status after loading dose have a predictive value for final visual acuity. CONCLUSIONS: The status of ISe and ELM bands after twelve months of treatment with ranibizumab was associated with visual outcome. Initial visual acuity and status of the ISe band after loading dose are prognostic factors of final visual acuity


Subject(s)
Female , Humans , Male , Macular Degeneration/diagnosis , Macular Degeneration/pathology , Tomography, Optical/instrumentation , Tomography, Optical/methods , Retinal Rod Photoreceptor Cells/cytology , Retinal Rod Photoreceptor Cells/metabolism , Macular Degeneration/classification , Macular Degeneration/metabolism , Tomography, Optical/classification , Tomography, Optical , Retinal Rod Photoreceptor Cells/classification , Retinal Rod Photoreceptor Cells , Retrospective Studies
6.
Arch Soc Esp Oftalmol ; 90(4): 156-63, 2015 Apr.
Article in Spanish | MEDLINE | ID: mdl-25620678

ABSTRACT

OBJECTIVE: To evaluate macular morphological parameters measured by spectral domain optical coherence tomography (SD-OCT) as predictive factors of visual outcome in patients with exudative age-related macular degeneration (AMD) treated with ranibizumab. METHODS: A retrospective study was conducted on 47 patients diagnosed with exudative AMD and treated with intravitreal ranibizumab for twelve months. Central retinal thickness (CRT), extension and thickness of modifications secondary to neovascular process, and status of the bands corresponding to the external limiting membrane (ELM) and to the ellipsoid region of the photoreceptors (ISe) were evaluated by means of SD-OCT. The relationship between these variables and visual acuity was analyzed by statistical methods. RESULTS: At the time of the diagnosis, preservation of ELM and ISe bands, and CRT were correlated with initial visual acuity. Twelve months later, CRT and visual acuity were independent parameters. Bivariate relationship analysis showed a correlation between final visual acuity and the following parameters: initial CRT, initial ISe and ELM status, and ISe and ELM integrity after loading dose. Multiple regression analysis indicated that initial visual acuity and ISe band status after loading dose have a predictive value for final visual acuity. CONCLUSIONS: The status of ISe and ELM bands after twelve months of treatment with ranibizumab was associated with visual outcome. Initial visual acuity and status of the ISe band after loading dose are prognostic factors of final visual acuity.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Macular Degeneration/diagnostic imaging , Macular Degeneration/drug therapy , Ranibizumab/therapeutic use , Tomography, Optical Coherence , Aged , Aged, 80 and over , Female , Humans , Male , Prognosis , Retrospective Studies , Treatment Outcome , Visual Acuity
7.
Arch Soc Esp Oftalmol ; 86(9): 300-2, 2011 Sep.
Article in Spanish | MEDLINE | ID: mdl-21893265

ABSTRACT

CASE REPORT: We present the clinical case of a 68 year-old woman who developed a pupillary block acute glaucoma due to vitreous hernia into anterior chamber following posterior dislocation of the intraocular lens one month after an Nd:YAG capsulotomy. DISCUSSION: We should consider these symptoms in the differential diagnosis of pseudophakic acute glaucoma, especially when visualisation of the anterior chamber is difficult due to corneal oedema and Nd:YAG capsulotomy was done.


Subject(s)
Glaucoma/etiology , Laser Therapy , Lens Capsule, Crystalline/surgery , Lens Subluxation/surgery , Lenses, Intraocular/adverse effects , Postoperative Complications/etiology , Pseudophakia/surgery , Pupil Disorders/etiology , Acute Disease , Aged , Brimonidine Tartrate , Combined Modality Therapy , Dipyrone/administration & dosage , Dipyrone/therapeutic use , Drug Therapy, Combination , Emergencies , Female , Furosemide/administration & dosage , Furosemide/therapeutic use , Glaucoma/diagnosis , Glaucoma/drug therapy , Glaucoma/surgery , Hernia/etiology , Humans , Iris/surgery , Lasers, Solid-State , Mannitol/administration & dosage , Mannitol/therapeutic use , Metoclopramide/administration & dosage , Metoclopramide/therapeutic use , Postoperative Complications/diagnosis , Postoperative Complications/drug therapy , Postoperative Complications/surgery , Pupil Disorders/diagnosis , Pupil Disorders/surgery , Quinoxalines/administration & dosage , Quinoxalines/therapeutic use , Timolol/administration & dosage , Timolol/therapeutic use , Vitrectomy , Vitreous Body/pathology
8.
Arch. Soc. Esp. Oftalmol ; 86(9): 300-302, sept. 2011. ilus
Article in Spanish | IBECS | ID: ibc-94290

ABSTRACT

Caso clínico: Se describe el caso clínico de una mujer de 68 años que presentó un glaucoma agudo secundario a un bloqueo pupilar por herniación vítrea a cámara anterior tras luxación de la lente intraocular a cámara vítrea un mes después de capsulotomía Nd:YAG.DiscusiónSe debe considerar este cuadro clínico en el diagnóstico diferencial del glaucoma agudo seudofáquico, especialmente si existe el antecedente de capsulotomía Nd:YAG y el edema corneal impide una correcta visualización de la cámara anterior (AU)


Case report: We present the clinical case of a 68 year-old woman who developed a pupillary block acute glaucoma due to vitreous hernia into anterior chamber following posterior dislocation of the intraocular lens one month after an Nd:YAG capsulotomy.DiscussionWe should consider these symptoms in the differential diagnosis of pseudophakic acute glaucoma, especially when visualisation of the anterior chamber is difficult due to corneal oedema and Nd:YAG capsulotomy was done (AU)


Subject(s)
Humans , Female , Middle Aged , Glaucoma/complications , Pupil Disorders/complications , Lenses, Intraocular/adverse effects , Lenses, Intraocular , Lens Implantation, Intraocular/methods , Lens Implantation, Intraocular/trends , Lasers, Solid-State/therapeutic use , Glaucoma/physiopathology , Glaucoma , Lenses, Intraocular/trends , Lens Implantation, Intraocular/adverse effects , Lens Implantation, Intraocular/standards , Fluorophotometry , Diagnosis, Differential
SELECTION OF CITATIONS
SEARCH DETAIL
...